ARCHIVES

New Phase III Follow-Up Data of Yervoy Trial Shows 19 Percent Survival at Four Years

This article is from The Cancer Letter archive.

Vol. 35 No. 10 | October 26, 2012

Download PDF Visit The Full Archive

Related Articles

Professional Societies: ASCO Develops Cancer Genetics Curriculum

December 18, 1998

NIH Limits Increases In Competing Renewals To Biomedical Deflator

August 30, 1991

Low Dose DFMO Reduces Colon Adenoma Recurrence

April 25, 2008

NCI Approved Clinical Trials

May 28, 2010

John Durant Is Chosen “Cancer Fighter of the Year”.

May 17, 2002

Tumor Cells In Blood May Indicate Aggressive Cancer

April 25, 2003